AI framework identifies clinically significant prostate cancer in intermediate-risk patients, suggesting reduced biopsies. Enhanced outcomes with representation learning aid radiologists in PI-RADS 3 assessments.
Motivation: Although MRI has a high negative predictive value for low-risk prostate cancers (PCa), it suffers from substantially high-number of false-positives for intermediate-risk cases, resulting in unnecessary biopsies. Goal(s): To develop an AI-based framework to detect clinically significant PCa (csPCa) in patients diagnosed as intermediate-risk by radiologists. Approach: We use PI-RADS-guided contrastive learning to generate latent representations from MR images. These serve as a guide to disambiguate PI-RADS3 and provide a tool for identifying potential negative biopsies. Results: We observe performance comparable to radiologists in identifying csPCa. Improved performance is noted in PI-RADS3 assessments where 10-28% negative biopsies can be avoided with appropriate risk-thresholds. Impact: Powered with PI-RADS guided representational learning, deep learning models can provide radiologists with additional information to disambiguate intermediate risk PI-RADS3 assessments, avoiding unnecessary biopsies, and potentially helping patient retention in active surveillance protocols.
No takes yet. Share an insight, caveat, or question.
Umapathy et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: